The event has been closed.

Signal Transduction and Targeted Therapy（ISSN 2059-3635（online），ISSN 2095-9907（print），CN 51-1758/R），于2016年创刊，旨在发表信号传导和靶向治疗等基础科学和临床研究的最新成果，目前期刊已创刊5年，经过长时间的经验累积，对国内英文期刊创刊有了自己的一些经验和认识，现邀请药物化学和生物学治疗领域专家学者共同探讨研究。

沙龙时间：2021年5月28日-5月29日

沙龙地点：四川大学生物治疗国家重点实验室生物楼一楼大会议室

面向人群：药物化学生物学学者及高校学生

1、本次活动免费。

2、报名的朋友们如果提供的email和手机号码无误，我们会在活动开始前一天发送短信和邮件确认。所以请确认自己填写的email地址无误。如果未收到确认函，可致电话：132-8122-2332 进行咨询

3、本活动欢迎大家带自己的同事和朋友一起参加，不过为了确保良好的听课环境，请尽可能提前为他们报名。

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, particularly on cancer. 

Signal Transduction and Targeted Therapy is a multidisciplinary journal, covering topics including but not limited to molecular biology, cell biology, pharmacology, medicinal chemistry, computational chemistry, systems biology, bioinformatics, and clinical medicine.

The editorial team of Signal Transduction and Targeted Therapy is composed of a highly respected editorial board of researchers from across the globe, led by the internationally renowned Professor Carlo M. Croce, together with Professor Kang Zhang and Professor Yu-Quan Wei.

This journal is now indexed in Pubmed Central (PMC) , Scopus, Directory of Open Access Journals (DOAJ) and BIOSIS